Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by JonEcashon Jul 05, 2011 3:25pm
325 Views
Post# 18797786

Financing participation...

Financing participation...SERNOVA CORP. ("SVA")
BULLETIN TYPE: Private Placement-Brokered
BULLETIN DATE: June 29, 2011
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Brokered Private Placement announced May 10, 2011:

Number of Shares: 5,337,914 shares

Purchase Price:
.19 per share

Warrants: 5,337,914 share purchase warrants to purchase 5,337,914 shares

Warrant Exercise Price:
.20 for a one year period


.35 in the second year

Number of Placees: 37 placees

Insider / Pro Group Participation:

Insider=Y /
Name ProGroup=P / # of Shares

George Adams Y 85,000
Philip Toleikis Y 78,947
James Rogers P 132,000


Agent's Fee: $29,693.20, Corporate Finance Fee of$25,000, and 195,950 non-transferable Broker Warrants exercisable at aprice of
.19 for an 18 month period, payable to Macquarie PrivateWealth Inc.

Pursuant to Corporate Finance Policy 4.1, Section1.11(d), the Company must issue a news release announcing the closing ofthe private placement and setting out the expiry dates of the holdperiod(s). The Company must also issue a news release if the privateplacement does not close promptly. [Note that in certain circumstancesthe Exchange may later extend the expiry date of the warrants, if theyare less than the maximum permitted term.]
Bullboard Posts